Nephritic syndromes: Pathology review

Last updated: November 01, 2022

Nephritic syndromes: Pathology review

Watch later

Watch later

TF/Px ratio and TF/Pinulin
Measuring renal plasma flow and renal blood flow
Regulation of renal blood flow
Tubular reabsorption and secretion
Hypocalcemia
Renal tubular acidosis
Minimal change disease
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Amyloidosis
Membranous nephropathy
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
IgA nephropathy (NORD)
Alport syndrome
Kidney stones
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Prerenal azotemia
Renal azotemia
Acute tubular necrosis
Postrenal azotemia
Renal papillary necrosis
Renal cortical necrosis
Chronic kidney disease
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary cystic kidney disease
Medullary sponge kidney
Renal artery stenosis
Renal cell carcinoma
Angiomyolipoma
Nephroblastoma (Wilms tumor)
WAGR syndrome
Beckwith-Wiedemann syndrome
Posterior urethral valves
Hypospadias and epispadias
Vesicoureteral reflux
Bladder exstrophy
Urinary incontinence
Neurogenic bladder
Lower urinary tract infection
Transitional cell carcinoma
Non-urothelial bladder cancers
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Endocrine system anatomy and physiology
Hunger and satiety
Insulin
Glucagon
Somatostatin
Diabetes mellitus
Diabetic retinopathy
Pancreatic neuroendocrine neoplasms
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes insipidus and SIADH: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Diabetes mellitus: Pathology review
Prostate cancer
Prostate gland histology
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Euthyroid sick syndrome
Thyroid hormones
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Hypothyroidism
Thyroglossal duct cyst
Riedel thyroiditis
Thyroid cancer
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Hyperparathyroidism
Hypoparathyroidism
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Zollinger-Ellison syndrome
Carcinoid syndrome
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Multiple endocrine neoplasia: Pathology review
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Synthesis of adrenocortical hormones
Cortisol
Testosterone
Estrogen and progesterone
Parathyroid hormone
Calcitonin
Adrenocorticotropic hormone
Growth hormone and somatostatin
Oxytocin and prolactin
Pituitary gland histology
Pancreas histology
Thyroid and parathyroid gland histology
Adrenal gland histology
Iron deficiency anemia
Alpha-thalassemia
Beta-thalassemia
Sideroblastic anemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Sickle cell disease (NORD)
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Aplastic anemia
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Hemolytic-uremic syndrome
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Antithrombin III deficiency
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Leukemoid reaction
Langerhans cell histiocytosis
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Anatomy of the thyroid and parathyroid glands
Pharyngeal arches, pouches, and clefts
Blood histology
Blood components
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Anatomy clinical correlates: Other abdominal organs
Anatomy of the male urogenital triangle
Membranoproliferative glomerulonephritis

Transcript

Watch video only

On the nephrology ward, two people came in with the same symptoms: peripheral and periorbital edema, along with cola-colored urine, arterial hypertension and decreased urine output.

The first person is 10 year old Timmy who had a throat infection two weeks ago.

The second one is 45 year old Dorothy, who also presents with hemoptysis.

Lab tests show that both of them have increased creatinine and BUN.

On urinalysis, there’s hematuria and red blood cell casts in the urine.

A 24-hour protein collection was done and showed that both Timmy and Dorothy had proteinuria, but in both cases it was less than 3.5 grams per day.

Now, both Timmy and Dorothy have nephritic syndrome.

Nephritic syndrome is typically caused by inflammation that damages the glomerular basement membrane, leading to hematuria and red blood cell casts in the urine.

Eventually, this damage can lead to renal failure, where the individual can present with oliguria, arterial hypertension, due to sodium retention, and peripheral and periorbital edema.

Lab tests show high levels of BUN and creatinine and on urinalysis, there’s hematuria, proteinuria and RBC casts in the urine.

A 24-hour protein collection is necessary to quantify how many proteins are lost through urine.

Now, nephritic syndrome can be differentiated from nephrotic syndrome because the proteinuria is generally under 3.5 grams per day, or within the “subnephrotic range”.

In severe cases though, proteinuria can reach over 3.5 grams per day.

In order to determine the cause, a careful history and a kidney biopsy can help diagnose the particular disease.

Okay, let’s start talking about the different disorders that could cause nephritic syndrome.

To make things simpler, we can categorize these into three groups; those caused by type III hypersensitivity, like poststreptococcal glomerulonephritis, IgA nephropathy, and Diffuse proliferative glomerulonephritis; those with multiple potential causes, like membranoproliferative glomerulonephritis, and rapidly progressive glomerulonephritis; and finally, Alport syndrome which is caused by a defect in collagen synthesis.

For the diseases that are only caused by a type III hypersensitivity reaction, let’s start with acute poststreptococcal glomerulonephritis or PSGN, which is most frequently seen in children, a very high yield fact.

Poststreptococcal glomerulonephritis can happen 2 to 4 weeks after a group A streptococcal infection of the pharynx or the skin, like impetigo.

Some group A streptococci strains carry the M-protein virulence factor, which initiates a type III hypersensitivity reaction where antibodies, often IgG and IgM, form immune complexes with the bacterial antigen.

These immune complexes travel to the glomerulus through the blood and deposit in the glomerular basement membrane or GBM.

Most of the time they’re subepithelial, meaning between the podocytes and the basement membrane.

The immune complexes initiate an inflammatory reaction in the glomerulus, which involves activation and deposition of C3 complement, inflammatory cytokines, oxidants, and proteases that damage the podocytes.

For your test, remember that lab tests show low levels of C3 in the blood and strep titers and serologies are positive.

Although a kidney biopsy isn’t always necessary, when it’s done, it can provide some specific clues.

On light microscopy, the glomeruli are enlarged and hypercellular.

On immunofluorescence, there are IgG, IgM and C3 deposits along the glomerular basement membrane and the mesangium, which create a specific “starry sky” appearance.

On electron microscopy, there are subepithelial deposits which appear as “humps”.

PSGN usually resolves on its own in children, but in adults, it can sometimes lead to renal failure, so another high-yield fact is that age affects prognosis.

Next on the list is IgA nephropathy, formerly called Berger’s disease .

This happens when abnormal IgA form in the body and the immune system recognizes them as foreign.

In response, the body generates IgG antibodies that target these IgAs, forming immune complexes which travel through the bloodstream and then get trapped in the kidney.

The immune complexes specifically deposit in the mesangium which is the tissue in the Bowman’s capsule that offers structural support to the glomerular capillaries.

The IgA-IgG immune complexes activate the alternative complement pathway, leading to the release of proinflammatory cytokines and migration of macrophages into the kidney, all of which contributes to glomerular injury.

What’s absolutely important to remember for your tests is that IgA antibodies are mainly secreted by the mucosal tissues of the respiratory and GI tract, so a high yield fact is that IgA nephropathy usually accompanies a respiratory or a GI infection.

On light microscopy, there’s mesangial proliferation.

On immunofluorescence, there are IgA immune complexes in the mesangium and on electron microscopy, the immune complexes are again seen in the mesangium.

Okay, now your test might try to confuse you by presenting a similar disorder called IgA vasculitis, also known as Henoch-Schonlein purpura.

Remember, the difference is IgA nephropathy only affects the kidneys, while IgA vasculitis can cause nephritic or nephrotic syndrome, but it also presents with colicky abdominal pain, bloody stool, arthritis, and palpable skin lesions.

Let’s move on to Diffuse proliferative glomerulonephritis, which is often caused by systemic lupus erythematosus.

Lupus is an autoimmune condition that affects multiple organs, including the kidneys.

This is another example of type III hypersensitivity reaction, where immune complexes are formed and deposited in various parts of the body.

Once they reach the kidney, they initiate an inflammatory reaction that leads to nephritic syndrome.

Lupus nephritis is classified depending on the exact site of these immune complexes and subsequent inflammatory reaction.

With diffuse proliferative glomerulonephritis, diffuse means that more than 50% of the glomeruli in both kidneys are affected.

The most common site of deposition is in the subendothelial space, meaning between the endothelial wall and the glomerular basement membrane.

On light microscopy, the immune complexes create an overall thickening of the capillary wall, which gives a “wire loop” appearance.

On immunofluorescence, there are granular immune complexes.

On electron microscopy, you can see sub-endothelial immune complexes.

Okay, we’ve covered the conditions that are mainly caused by type III hypersensitivity reaction.

Next we’ll talk more complex conditions that could have multiple causes.

First, there’s membranoproliferative glomerulonephritis or MPGN.

There are actually three types of MPGN, but they all cause proliferation of mesangial and endothelial cells in the glomerulus.

We’ll only go through the first two, since the third type isn’t well understood.

Type I MPGN is the most common form, and it can be idiopathic or secondary to hepatitis B or hepatitis C infection.

Type I MPGN usually starts one of two ways.

The first way is through type III hypersensitivity reaction where there are circulating immune complexes made from antibodies bound to antigens released from hepatitis B or hepatitis C, infections, and this is another very high yield fact!

Over time, many of these immune complexes that circulate in the body reach the glomerulus and activate the complement system through the classical pathway, also causing complement deposition.

These immune complexes end up in the subendothelium, meaning between the endothelial wall and the glomerular basement membrane.

The second way is not caused by a hypersensitivity reaction, but it involves the inappropriate activation of the alternative pathway of the complement system.

With this pathway, C3 is converted to C3a and C3b by an enzyme called C3 convertase.

Inappropriate activation of this enzyme could be caused by a genetic mutation, or a special IgG autoantibody, called “nephritic factor” or C3NeF.

This IgG binds to the C3 convertase, stabilising it and allows it to continue working.

This “long-life” C3 convertase keeps on converting C3 to C3a and C3b.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Practical Renal Pathology, A Diagnostic Approach E-Book" Elsevier Health Sciences (2012)
  4. "Physiology E-Book" Elsevier Health Sciences (2017)
  5. "Rosen's Emergency Medicine" P. Rosen (2018)
  6. "The Renal System" Churchill Livingstone (2010)
  7. "Introduction: Glomerular Disease Update for the Clinician" Clinical Journal of the American Society of Nephrology (2016)
  8. "Hemolytic Uremic Syndrome" Pediatric Clinics of North America (2019)
  9. "Goodpasture's disease" The Lancet (2001)